|
Use of the Mo.Ma proximal cerebral protection device (Invatec) with FDA-approved carotid stents in high-risk patients are 98 percent effective and proved to decrease the risk of stroke, according to results of the ARMOUR trial presented by Barry T. Katzen, MD, at the 35th annual Society of Interventional Radiology Scientific Meeting March 15.
Researchers using high-resolution imaging to track changes to individual dendritic spines--points of contact between nerve cells--found that behavioral learning results when instructive experience is able to rapidly stabilize and strengthen synapses on sensorimotor neurons, according to a study conducted by Richard Mooney, PhD, professor of neurobiology at Duke University Medical Center, in Durham, N.C., and colleagues.
Huntsville Hospital, a Joint Commission-certified stroke center in Huntsville, Ala., is contacting 60 patients who may have received similar radiation doses with CT brain perfusion as those who were overexposed at Cedars-Sinai Medical Center in Los Angeles.
Shelagh B. Coutts, MD, was granted the first Distinguished Clinician Scientist 2009 award by the Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health and AstraZeneca Canada during the Canadian Cardiovascular Congress this week in Edmonton, Alberta.
Kaiser Permanente has received 22 grants worth more than $54 million from the National Institutes of Health (NIH) through the American Recovery and Reinvestment Act (ARRA) of 2009.
Patients at highly rated hospitals have a 52 percent lower chance of dying compared with the U.S. hospital average—a quality chasm that has persisted for the last decade even as mortality rates have generally declined, according to the annual study of patient outcomes at 5,000 U.S. nonfederal hospitals published Tuesday by HealthGrades.
Strokes occur in infants and children much more frequently than previously reported, according to a study in Stroke: Journal of the American Heart Association.
In vivo MRI results demonstrate that mesenchymal stem cells migrate toward a quinolinic acid lesion and can survive for 19 days post-transplantation, which gives hope for future research harnessing stem cells for treating neurodegenerative diseases, such as Huntington's, Alzheimer's and Parkinson's, according to research in this month’s issue of Stem Cells.
The British Heart Foundation Glasgow Cardiovascular Research Centre at Glasgow University in Scotland has ordered a Magnetom Verio 3T MRI scanner from Siemens Healthcare.
Areas of brain damage, indicated through white matter hyperintensity volume and infarcts seen on brain MRI, which originally thought to be related to stroke, may help doctors predict a person's risk of memory problems in old age, according to research published in today's issue of Neurology.
|
Surgery with molecular fluorescence imaging using a dual fluorescent plus a magnetic marker decreases residual cancer, improves survival and MRI-guided clinical staging, according to two studies published in the March issue of Proceedings of the National Academy of Sciences.
Siemens Healthcare has developed a new application for interventional radiology, the Syngo Neuro PBV IR.
Biophysicists from the University of Rhode Island in Kingston have reported they have discovered a technology that can detect cancerous tumors and deliver treatment to them without harming the healthy cells surrounding them, thereby significantly reducing side effects.
Toshiba America Medical Systems is showcasing a cornucopia of diagnostic imaging technologies at the 2009 Radiological Society of North America’s (RSNA) conference.
Increased FDG uptake in major arteries emerged as a strong predictor of a subsequent vascular event, according to a study in this month’s Journal of Nuclear Medicine.
The FDA is conducting a safety investigation of radiation overexposures during perfusion CT imaging to aid in the diagnosis and treatment of stroke.
NeuroLogica has received FDA 510(k) clearance for its portable SPECT system, the inSPira HD.
Scientists from the U.S. Department of Energy's Argonne National Laboratory in Argonne, Ill., and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using titanium dioxide nanoparticles bound to biological material. The nano-bio technology may eventually provide an alternative form of therapy that targets only cancer cells and does not affect normal tissue.
The development of new light-emitting biomaterial at the University of Virginia, reported in a study in the current online edition of Nature Materials, could simplify the imaging of oxygen-deficient areas of tumors.
The Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE) consortium is studying effective medical imaging methods to help diagnose and treat patients with Alzheimer's disease, stroke and cancer.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.